Evoke Wealth, LLC Editas Medicine, Inc. Transaction History

Evoke Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$14.08 - $27.63 $887 - $1,740	-63 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$26.55 - $40.57 $1,672 - $2,555	63 New	63 $2,000
Q1 2020 May 07, 2020	SELL	$14.88 - $32.78 $1,041 - $2,294	-70 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$22.49 - $26.81 $1,574 - $1,876	70 New	70 $1.59 Million

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $164M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.